DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Receives FDA Fast Track Designation for Varoglutamstat in Early Alzheimer's Disease

DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Miscellaneous Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Receives FDA Fast Track Designation for Varoglutamstat in Early Alzheimer's Disease (news with additional features) 22.12.2021 / 07:00 The issuer is solely responsible for the con...

Related Keywords

Amsterdam ,Noord Holland ,Netherlands ,Germany ,Munich ,Bayern ,Berlin ,Valeria Fisher Sophia Hergenhan ,Ulrich Dauer ,Halle Saale ,Manuela Bader ,Drug Administration ,News Service ,Trophic Communications ,Distribution Services ,Vivoryon Therapeutics Receives ,Track Designation ,Early Alzheimer ,Germany December ,Euronext Amsterdam ,Fast Track ,European Phase ,Accelerated Approval ,Priority Review ,Vivoryon Fast Track ,Corporate News ,Regulatory Announcements ,Unofficial Market ,Vivoryon ,Herapeutics ,Env ,Eceives ,Fda ,Mast ,Track ,Resignation ,Aroglutamstat ,Early ,Alzheimer S ,Disease ,The ,